DE3070508D1 - Ubidecarenone composition enhancing the absorption - Google Patents

Ubidecarenone composition enhancing the absorption

Info

Publication number
DE3070508D1
DE3070508D1 DE8080104371T DE3070508T DE3070508D1 DE 3070508 D1 DE3070508 D1 DE 3070508D1 DE 8080104371 T DE8080104371 T DE 8080104371T DE 3070508 T DE3070508 T DE 3070508T DE 3070508 D1 DE3070508 D1 DE 3070508D1
Authority
DE
Germany
Prior art keywords
absorption
composition enhancing
ubidecarenone
ubidecarenone composition
enhancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080104371T
Other languages
German (de)
English (en)
Inventor
Kazuo Taki
Hideo Takahira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3070508D1 publication Critical patent/DE3070508D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE8080104371T 1979-07-25 1980-07-24 Ubidecarenone composition enhancing the absorption Expired DE3070508D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9363679A JPS5618914A (en) 1979-07-25 1979-07-25 Ubidecarenone composition having good absorbability

Publications (1)

Publication Number Publication Date
DE3070508D1 true DE3070508D1 (en) 1985-05-23

Family

ID=14087821

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080104371T Expired DE3070508D1 (en) 1979-07-25 1980-07-24 Ubidecarenone composition enhancing the absorption

Country Status (7)

Country Link
US (1) US4325942A (enExample)
EP (1) EP0023349B1 (enExample)
JP (1) JPS5618914A (enExample)
CA (1) CA1159767A (enExample)
DE (1) DE3070508D1 (enExample)
ES (1) ES8106408A1 (enExample)
PH (1) PH16762A (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
EP0104043A3 (en) * 1982-09-20 1984-06-06 Ajinomoto Co., Inc. Foodstuffs and pharmaceuticals
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4824669A (en) * 1985-04-11 1989-04-25 Board Of Regents, The University Of Texas System Formulations of coenzyme Q10 for intravenous use
JPH0629180B2 (ja) * 1986-06-16 1994-04-20 エーザイ株式会社 吸収性の改良されたメナテトレノン含有組成物
JPH01501153A (ja) * 1986-10-23 1989-04-20 アルバル・エッセ・ピ・ア ユビデカレノン類を含有する化粧品
JPS63188623A (ja) * 1987-01-31 1988-08-04 Taisho Pharmaceut Co Ltd 吸収改善ユビデカレノン製剤
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
EP0543943B1 (en) * 1990-08-13 1995-04-26 YESAIR, David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5571517A (en) * 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
JP3106820B2 (ja) * 1993-12-08 2000-11-06 アールティーエー・アソシエーツ有限会社 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
AU728695B2 (en) * 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
DE10133305B4 (de) 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
JP2003055204A (ja) * 2001-08-21 2003-02-26 Sansho Iyaku Kk ユビデカレノン組成物及び同組成物を内容物とするカプセル
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
JP5258144B2 (ja) * 2004-12-21 2013-08-07 株式会社分子生理化学研究所 吸収性の改善された固形状のコエンザイムｑ１０経口製剤の製造方法
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
JP5181497B2 (ja) * 2007-03-05 2013-04-10 大正製薬株式会社 ユビデカレノン含有固形製剤用組成物
PL2544663T3 (pl) 2010-03-12 2018-09-28 Berg Llc Dożylne formulacje koenzymu Q10 (CoQ10) i sposoby ich zastosowania

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317381A (en) * 1965-10-04 1967-05-02 Takeda Chemical Industries Ltd Method for treating peptic ulcer
US3426125A (en) * 1965-04-07 1969-02-04 Yukio Shigeta Method of treating diabetes mellitus
US3534137A (en) * 1965-09-30 1970-10-13 Takeda Chemical Industries Ltd Method of systemic therapy for severe early destructive periodontal disease
US3452144A (en) * 1966-03-26 1969-06-24 Takeda Chemical Industries Ltd Method for treatment of congestive heart failure with coenzyme qn
US3808330A (en) * 1972-07-13 1974-04-30 Eisai Co Ltd Method for treatment of hypertensive disease
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
DE2700501A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation
DE2700371A1 (de) * 1977-01-07 1978-07-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation
DE2700433A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Arzneimittelzubereitungen mit verbesserten resorptionseigenschaften

Also Published As

Publication number Publication date
JPS5618914A (en) 1981-02-23
US4325942A (en) 1982-04-20
EP0023349A2 (en) 1981-02-04
CA1159767A (en) 1984-01-03
JPS6410494B2 (enExample) 1989-02-22
EP0023349B1 (en) 1985-04-17
ES493679A0 (es) 1981-07-01
EP0023349A3 (en) 1982-03-10
PH16762A (en) 1984-02-15
ES8106408A1 (es) 1981-07-01

Similar Documents

Publication Publication Date Title
DE3070508D1 (en) Ubidecarenone composition enhancing the absorption
GB2046283B (en) Soloxane composition
JPS565899A (en) Claning composition
PH15735A (en) Deodorant compositions
JPS5695994A (en) Shampoo composition
PH15855A (en) Deodorant compositions
JPS5634751A (en) Polycarbonateepolyolefin composition
JPS55129447A (en) Composition
JPS5682839A (en) Waterrabsorbable composition
JPS56100347A (en) Laserrexpanded xxray absorption fineestructure
GB8310267D0 (en) Compositions as cosmetics
HK66785A (en) Solid acetylsalicylate composition
EG15103A (en) Oxytetrocycline compositions
JPS565406A (en) Tickicidal composition
JPS5691075A (en) Size composition
JPS55129229A (en) Indiumm1111oxine complex composition
JPS5653745A (en) Structure for absorption
JPS5622734A (en) Composition
JPS5649747A (en) Ureaaformaldehyde composition
JPS5639010A (en) Deodorant composition
GB2059432B (en) Anti-freeze composition
JPS5455763A (en) Drink composition
JPS5620099A (en) Shampoo composition
JPS56135531A (en) Composition
JPS55118957A (en) Flameeproof composition

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee